Abstract: A connection adapter for incorporating in a riser stack of an underground tank includes a first portion, a flange portion, and a pipe stub. The first portion has a bottom end and a top end opposite the bottom end. The bottom end has an outer diameter sized to fit within an accessway of the underground tank. The flange portion is connected to the top end of the first portion. The pipe stub is in fluid communication with the first portion and externally protrudes from the first portion. The pipe stub is integrally formed with the first portion and has an integrally formed distal end wall caps the pipe stub.

Abstract: A connection adapter for incorporating in a riser stack of an underground tank includes a first portion, a flange portion, and a pipe stub. The first portion has a bottom end and a top end opposite the bottom end. The bottom end has an outer diameter sized to fit within an accessway of the underground tank. The flange portion is connected to the top end of the first portion. The pipe stub is in fluid communication with the first portion and externally protrudes from the first portion. The pipe stub is integrally formed with the first portion and has an integrally formed distal end wall caps the pipe stub.

Abstract: A surface modified ophthalmic device includes a silicone ophthalmic device having a hydrophilic surface coating attached to a surface of the silicone ophthalmic device by van der Waals dispersion forces, the hydrophilic surface coating comprising a copolymer comprising (i) monomeric units derived from an ethylenically unsaturated-containing monomer having ring-opening reactive functionalities, and (ii) monomeric units derived from a hydrophilic monomer having an ethylenically unsaturated reactive group.

Abstract: Provided herein are GI specific rifaximin release compositions which can be formulated for targeted delivery of rifaximin to one or more portions of the GI tract. Methods of treating diseases and disorders with the disclosed compositions are also provided.

Abstract: Provided herein are GI specific rifaximin release compositions which can be formulated for targeted delivery of rifaximin to one or more portions of the GI tract. Methods of treating diseases and disorders with the disclosed compositions are also provided.

Abstract: Provided herein are GI specific rifaximin release compositions which can be formulated for targeted delivery of rifaximin to one or more portions of the GI tract. Methods of treating diseases and disorders with the disclosed compositions are also provided.

Abstract: A technology is described for determining compliance with security technical implementation guide (STIG) standards. An example of the technology can include identifying a STIG standard that may be applicable to a system component included in a computer system. The STIG standard can be obtained from a security technical implementation guide which specifies security standards for securing computer systems against unauthorized access. A configuration compliance package can be generated to evaluate a configuration setting of the system component for compliance to the STIG standard, and the configuration compliance package can be output to enable a determination of compliance of the configuration setting with the STIG standard.

Abstract: A technology is described for determining compliance with security technical implementation guide (STIG) standards. An example of the technology can include identifying a STIG standard that may be applicable to a system component included in a computer system. The STIG standard can be obtained from a security technical implementation guide which specifies security standards for securing computer systems against unauthorized access. A configuration compliance package can be generated to evaluate a configuration setting of the system component for compliance to the STIG standard, and the configuration compliance package can be output to enable a determination of compliance of the configuration setting with the STIG standard.